The settlement also bars Allergan and its subsidiaries from selling opioids in New York for the next decade. Allergan, best known for making Botox, discontinued its branded opioids business in 2020, a spokesperson for AbbVie, Allergan’s parent company, told The New York Times.
The agreement is part of sweeping opioids litigation that New York state and two counties filed against drugmakers, distributors and pharmacy chains in June.
Several companies, including Johnson & Johnson and CVS Health, have already inked settlements with New York. Teva Pharmaceuticals and its subsidiary Anda are the two remaining defendants in the case.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
